These are additional measures that are investigated during a clinical trial to determine if the drug has been effective or not.
Search Results for: clinical trial
Reading Time: 6 minutesMy name is Stephanie Shepheard, and I am a Research Associate in the Motor Neuron Disease & Neurotrophic Research Laboratory (MND&NR Lab), Flinders Health &
Reading Time: 5 minutesThis is a guest blog written by Danielle Boyce, DPA, MPH, Executive Director, the Robert Packard Center for ALS Research and Answer ALS Research Program;
Reading Time: 4 minutesThis is blog number 21 in our ‘Symposium Blogathon’ – counting down to the 32nd International Symposium on ALS/MND. Numbers in bold green type correspond
Reading Time: 4 minutesThis is blog number 17 in our ‘Symposium Blogathon’ – counting down to the 32nd International Symposium on ALS/MND. Numbers in bold green type correspond
Reading Time: 4 minutesThis is blog number 15 in our ‘Symposium Blogathon’ – counting down to the 32nd International Symposium on ALS/MND. Numbers in bold green type correspond
Reading Time: 6 minutesThis is blog number 14 in our ‘Symposium Blogathon’ – counting down to the 32nd International Symposium on ALS/MND. Numbers in bold green type correspond
32nd Symposium: Virtual Causes and disease mechanisms Healthcare Markers of Disease Progression MND Research Models of MND
32nd International Symposium: meet our plenary speakers (part 2)
Reading Time: 7 minutesThis is blog number 13 in our ‘Symposium Blogathon’ – counting down to the 32nd International Symposium on ALS/MND. Numbers in bold green type correspond
Reading Time: 5 minutesThis is blog number 12 in our ‘Symposium Blogathon’ – counting down to the 32nd International Symposium on ALS/MND. Numbers in bold green type correspond
Reading Time: 5 minutesThis is blog number 10 in our ‘Symposium Blogathon’ – counting down to the 32nd International Symposium on ALS/MND. Numbers in brackets correspond to the